Evidence map›Paper›PMID 31863406›Full record

Trial reportNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2020

One-Day Acceptance and Commitment Therapy Compared to Support for Depressed Migraine Patients: a Randomized Clinical Trial.

Lilian N Dindo, Ana Recober, Chadi A Calarge, Bridget M Zimmerman, Aliza Weinrib, James N Marchman, Carolyn Turvey

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02108678 (One-Day Intervention for Depression and Impairment in Migraine Patients), which is not on this map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02108678 nacompletednot on this map

One-Day Intervention for Depression and Impairment in Migraine Patients

TypeinterventionalSponsorBaylor College of MedicineRan2013 to 2017Enrolled104ConditionsMigraine, DepressionArmsACT-ME, Migraine Education Only
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Lilian N DindoHouston VA HSR&D Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey Veterans Affairs Medical Center, Holcombe, Houston, TX, 77030, USA. lilian.dindo@bcm.edu.
Ana RecoberUniversity of Pennsylvania & the Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Chadi A CalargeDepartment of Internal Medicine, Section of Health Services Research, Baylor College of Medicine, Houston, TX, USA.
Bridget M ZimmermanDepartment of Biostatistics, University of Iowa, Iowa City, IA, USA.
Aliza WeinribDepartment of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
James N MarchmanDepartment of Psychology, University of Iowa, Iowa City, IA, USA.
Carolyn TurveyDepartment of Psychiatry, University of Iowa, Iowa City, IA, USA.
University of Iowa · USBaylor College of Medicine · USCenter for Innovation · USUniversity Health Network · CAUniversity of Pennsylvania · US

Funding

One-day Intervention for Depression and Impairment in Migraine PatientsK23MH097827 · NIMH · UNIVERSITY OF IOWA · PI DINDO, LILIAN NAZAR · 2013 to 2016
$490k
NIMH NIH HHS K23 MH097827
6 · The paper itself

Abstract

In patients with migraine, depression is associated with poorer medical prognosis, decreased quality of life, and increased risk of suicidality and disability; yet, behavioral interventions have rarely been investigated. The current study compared the efficacy of two 1-day (5- to 6-h) interventions for co-occurring migraine and depression: (1) acceptance and commitment therapy plus migraine education (ACT-ED), and (2) support plus migraine education (S-ED). One hundred and thirty-six patients with comorbid depression and migraine were randomized to a treatment. One hundred and three (76%) completed the ACT-ED (N = 56) or S-ED (N = 47) workshop. Primary outcomes were depression diagnosis and symptoms. Secondary outcomes were anxiety symptoms, headache-related disability and general functioning, and quality of life. Assessments were completed at baseline and 3 and 6 months following the workshop. At the 6-month follow-up, on categorical outcomes, a significantly greater number of people in the ACT-ED condition no longer met criteria for a major depressive episode and exhibited a > 50% drop in symptoms on the Hamilton Rating Scale of Depression. Similarly, though, weaker results were found when examining depressive symptoms dimensionally. On secondary outcomes, people in the ACT-ED condition exhibited significantly greater improvements in anxiety, headache-related disability, and quality of social relationships, compared to S-ED, No differences between groups were observed in general functioning. A 1-day (5- to 6-h) ACT workshop can deliver substantial and lasting benefits to depressed migraineurs, over and above those provided by group support and education. This approach is an attractive alternative to weekly psychotherapy. Clinicaltrials.gov # NCT02108678.

Indexed as

Acceptance and Commitment TherapyAdultDepressionFemaleHumansMaleMiddle AgedMigraine DisordersPatient Education as TopicPsychotherapy, GroupTreatment OutcomeAcceptance and commitment therapy (ACT)DepressionIllness managementMigraine

Identifiers

PMID31863406
PMCPMC7283406
OpenAlexW2994970239

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.